Business Description
BetterLife Pharma Inc
NAICS : 325411
SIC : 3741
ISIN : CA72580T2020
Compare
Compare
Traded in other countries / regions
BETR.CanadaBETRF.USANPAU.Germany IPO Date
2018-03-19Description
BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumors to treat various types of cancer.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.15 | |||||
| Equity-to-Asset | -18 | |||||
| Debt-to-Equity | -0.07 | |||||
| Debt-to-EBITDA | -0.23 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 55.1 | |||||
| 3-Year EPS without NRI Growth Rate | 46 | |||||
| 3-Year FCF Growth Rate | 68.8 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 90.1 | |||||
| 9-Day RSI | 71.79 | |||||
| 14-Day RSI | 63.32 | |||||
| 6-1 Month Momentum % | 75.68 | |||||
| 12-1 Month Momentum % | 30 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.08 | |||||
| Quick Ratio | 0.08 | |||||
| Cash Ratio | 0.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -73.6 | |||||
| Shareholder Yield % | -14.55 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -706.7 | |||||
| ROIC % | -479.22 | |||||
| ROC (Joel Greenblatt) % | -39471.43 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -5.02 | |||||
| EV-to-EBITDA | -5.03 | |||||
| EV-to-FCF | -5.15 | |||||
| Earnings Yield (Greenblatt) % | -19.91 | |||||
| FCF Yield % | -17.66 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BetterLife Pharma Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.015 | ||
| Beta | 1.03 | ||
| Volatility % | 65.82 | ||
| 14-Day RSI | 63.32 | ||
| 14-Day ATR (€) | 0.00357 | ||
| 20-Day SMA (€) | 0.06375 | ||
| 12-1 Month Momentum % | 30 | ||
| 52-Week Range (€) | 0.0305 - 0.083 | ||
| Shares Outstanding (Mil) | 116.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BetterLife Pharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BetterLife Pharma Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
BetterLife Pharma Inc Frequently Asked Questions
What is BetterLife Pharma Inc(STU:NPAU)'s stock price today?
The current price of STU:NPAU is €0.07. The 52 week high of STU:NPAU is €0.08 and 52 week low is €0.03.
When is next earnings date of BetterLife Pharma Inc(STU:NPAU)?
The next earnings date of BetterLife Pharma Inc(STU:NPAU) is .
Does BetterLife Pharma Inc(STU:NPAU) pay dividends? If so, how much?
BetterLife Pharma Inc(STU:NPAU) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers